Literature DB >> 27197309

Prediabetes in California: Nearly Half of California Adults on Path to Diabetes.

Susan H Babey1, Joelle Wolstein1, Allison L Diamant2, Harold Goldstein3.   

Abstract

In California, more than 13 million adults (46 percent of all adults in the state) are estimated to have prediabetes or undiagnosed diabetes. An additional 2.5 million adults have diagnosed diabetes. Altogether, 15.5 million adults (55 percent of all California adults) have prediabetes or diabetes. Although rates of prediabetes increase with age, rates are also high among young adults, with one-third of those ages 18-39 having prediabetes. In addition, rates of prediabetes are disproportionately high among young adults of color, with more than one-third of Latino, Pacific Islander, American Indian, African-American, and multiracial Californians ages 18-39 estimated to have prediabetes. Policy efforts should focus on reducing the burden of prediabetes and diabetes through support for prevention and treatment.

Entities:  

Mesh:

Year:  2016        PMID: 27197309

Source DB:  PubMed          Journal:  Policy Brief UCLA Cent Health Policy Res


  11 in total

Review 1.  Dynamics of diabetes and obesity: Epidemiological perspective.

Authors:  Annette Boles; Ramesh Kandimalla; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-24       Impact factor: 5.187

2.  Description of a pharmacist-led diabetes prevention service within an employer-based wellness program.

Authors:  Courtney E Gamston; Anna N Kirby; Richard A Hansen; David T Redden; Heather P Whitley; Courtney Hanson; Kimberly B Lloyd
Journal:  J Am Pharm Assoc (2003)       Date:  2019-07-13

3.  Comparison of screening scores for diabetes and prediabetes.

Authors:  Eduard Poltavskiy; Dae Jung Kim; Heejung Bang
Journal:  Diabetes Res Clin Pract       Date:  2016-06-18       Impact factor: 5.602

4.  Traffic-related air pollution is associated with glucose dysregulation, blood pressure, and oxidative stress in children.

Authors:  Jennifer K Mann; Liza Lutzker; Stephanie M Holm; Helene G Margolis; Andreas M Neophytou; Ellen A Eisen; Sadie Costello; Tim Tyner; Nina Holland; Gwen Tindula; Mary Prunicki; Kari Nadeau; Elizabeth M Noth; Fred Lurmann; S Katharine Hammond; John R Balmes
Journal:  Environ Res       Date:  2021-02-12       Impact factor: 6.498

5.  A Framework for Implementing the National Diabetes Prevention Program in Los Angeles County.

Authors:  Jennifer T Mosst; Amelia DeFosset; Lauren Gase; Laura Baetscher; Tony Kuo
Journal:  Prev Chronic Dis       Date:  2017-08-24       Impact factor: 2.830

6.  Protocol for a cluster randomized controlled trial to study the effectiveness of an obesity and diabetes intervention (PASOS) in an immigrant farmworker population.

Authors:  Melissa R Borelli; Heather E Riden; Heejung Bang; Marc B Schenker
Journal:  BMC Public Health       Date:  2018-07-09       Impact factor: 3.295

Review 7.  Collaborative research and actions on both sides of the US-Mexico border to counteract type 2 diabetes in people of Mexican origin.

Authors:  Simón Barquera; Dean Schillinger; Carlos A Aguilar-Salinas; Marc Schenker; Luis A Rodríguez; Cesar Hernández-Alcaraz; Jaime Sepúlveda-Amor
Journal:  Global Health       Date:  2018-08-22       Impact factor: 4.185

8.  Food Bank-Based Diabetes Prevention Intervention to Address Food Security, Dietary Intake, and Physical Activity in a Food-Insecure Cohort at High Risk for Diabetes.

Authors:  Kate Cheyne; Morgan Smith; Elizabeth M Felter; Martha Orozco; Eric A Steiner; Yuae Park; Tiffany L Gary-Webb
Journal:  Prev Chronic Dis       Date:  2020-01-09       Impact factor: 2.830

Review 9.  Diabetes: Concepts of β-Cell Organ Dysfunction and Failure Would Lead to Earlier Diagnoses and Prevention.

Authors:  M Arthur Charles; R David Leslie
Journal:  Diabetes       Date:  2021-11       Impact factor: 9.461

10.  Estimated number of eligible Part B beneficiaries for the medicare diabetes prevention program at the county level and by urban-rural classification.

Authors:  Boon Peng Ng; Yiling J Cheng; Stephanie Rutledge; Michael J Cannon; Ping Zhang; Bryce D Smith
Journal:  PLoS One       Date:  2020-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.